Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q2 2019 · 10-Q
Revenue$124.56M$124.56M+1.7% vs Q2 2018 Net Income-$584.00K-$584.00KN/M vs Q2 2018 EPS Diluted-$0.02-$0.02N/M vs Q2 2018 Gross Profit$16,885,000+13.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,617,000−58.7% Free Cash Flowderived-$1,531,000N/M Margins · derivedGross margin13.6%+1.4 pt vs Q2 2018
Operating margin0.0%+0.6 pt vs Q2 2018
Net margin-0.5%−0.9 pt vs Q2 2018
ended Nov 25, 2018 · filed Jan 7, 2019 · 43 d after period end